Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder ; volume:14 ; number:1 ; day:12 ; month:2 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (12.2.2024), 1-12, 12.2024
- Creator
-
Ongphichetmetha, Tatchaporn
Jitprapaikulsan, Jiraporn
Siritho, Sasitorn
Rattanathamsakul, Natthapon
Detweeratham, Thammachet
Prayoonwiwat, Naraporn
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-53838-y
- URN
-
urn:nbn:de:101:1-2404220825516.219297166395
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ongphichetmetha, Tatchaporn
- Jitprapaikulsan, Jiraporn
- Siritho, Sasitorn
- Rattanathamsakul, Natthapon
- Detweeratham, Thammachet
- Prayoonwiwat, Naraporn
- SpringerLink (Online service)
Other Objects (12)
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
Emerging treatments for neuromyelitis optica spectrum disorder
Late Onset of Neuromyelitis Optica Spectrum Disorders
Neuromyelitis optica
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Use of rituximab and risk of re-hospitalization for children with neuromyelitis optica spectrum disorder
Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
Demyelinating syndrome in systemic sclerosis and neuromyelitis optica
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
Emerging treatments for neuromyelitis optica spectrum disorder
Late Onset of Neuromyelitis Optica Spectrum Disorders
Neuromyelitis optica
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Use of rituximab and risk of re-hospitalization for children with neuromyelitis optica spectrum disorder
Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
Demyelinating syndrome in systemic sclerosis and neuromyelitis optica
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
Emerging treatments for neuromyelitis optica spectrum disorder
Late Onset of Neuromyelitis Optica Spectrum Disorders
Neuromyelitis optica
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Use of rituximab and risk of re-hospitalization for children with neuromyelitis optica spectrum disorder
Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
Demyelinating syndrome in systemic sclerosis and neuromyelitis optica
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder